Skip to main content
Back
Watch Compare

PURE BIOSCIENCE, INC.

Data quality: 100%
PURE
OTC Manufacturing Chemicals
$0.09
▲ $0.01 (6.25%)
Mkt Cap: 9.51 M
Price
$0.09
Mkt Cap
9.51 M
Day Range
$0.08 — $0.09
52-Week Range
$0.04 — $0.21
Volume
15,155
Open $0.09
50D / 200D Avg
$0.06
32.40% above
50D / 200D Avg
$0.07
22.30% above

Quick Summary

Key Takeaways

Revenue declined -12.20% annually over 5 years
Negative free cash flow of -1.82 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 24.63%

Growth

Revenue Growth (5Y)
-12.20%
Below sector avg (9.35%)
Revenue (1Y)12.43%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net Margin-89.97%
Op. Margin-82.51%

Safety

Debt / Equity
N/A
Current Ratio0.25
Interest Coverage-5.74

Valuation

PE (TTM)
-4.40
Below sector avg (-1.98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -4.4 -2.0
P/B — 5.1
ROE % — -51.0
Net Margin % -90.0 -150.2
Rev Growth 5Y % -12.2 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 12.43% Revenue Growth (3Y) 8.39%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -12.20% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2.40 M Net Income (TTM) -2.16 M
ROE N/A ROA -218.95%
Gross Margin 59.91% Operating Margin -82.51%
Net Margin -89.97% Free Cash Flow (TTM) -1.82 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.25
Interest Coverage -5.74 Asset Turnover 2.43
Working Capital -2.28 M Tangible Book Value -6.27 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.40 Forward P/E N/A
P/B Ratio N/A P/S Ratio 3.96
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -19.18%
Market Cap 9.51 M Enterprise Value 9.31 M
Per Share
EPS (Diluted TTM) -0.02 Revenue / Share 0.02
FCF / Share -0.02 OCF / Share -0.02
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 84.41%
SBC-Adj. FCF -2.01 M Growth Momentum 24.63

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2.20 M 1.96 M 1.87 M 1.81 M 3.70 M
Net Income -2.40 M -3.35 M -3.96 M -3.49 M -2.32 M
EPS (Diluted) -0.02 -0.03 -0.04 — -0.03
Gross Profit 1.30 M 1.15 M 971,000.0 1.00 M 2.08 M
Operating Income -2.27 M -3.19 M -3.94 M -3.72 M -2.31 M
EBITDA — — — — —
R&D Expenses 316,000.0 302,000.0 297,000.0 319,000.0 339,000.0
SG&A Expenses 3.26 M 3.98 M 4.30 M 4.11 M 4.05 M
D&A 2,000.0 148,000.0 117,000.0 213,000.0 172,000.0
Interest Expense 287,000.0 155,000.0 14,000.0 6,000.0 4,000.0
Income Tax 0.0 0.0 1,650.0 1,650.0 1,650.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.06 M 818,000.0 1.83 M 4.48 M 4.30 M
Total Liabilities 6.17 M 3.68 M 1.55 M 575,000.0 970,000.0
Shareholders' Equity -5.12 M -2.86 M 272,000.0 3.91 M 3.33 M
Total Debt — — — — —
Cash & Equivalents 334,000.0 349,000.0 1.10 M 3.39 M 2.39 M
Current Assets 1.05 M 805,000.0 1.60 M 3.86 M 3.20 M
Current Liabilities 938,000.0 733,000.0 532,000.0 575,000.0 970,000.0